ALZN peer analysis
Alzamend Neuro (ALZN) against its competitors: price, today's move, 1-year return and market value side by side.
- ALZN's peers: ACXP (Acurx Pharmaceuticals), ADIL (Adial Pharmaceuticals), APRE (Aprea Therapeutics), BCDA (BioCardia), CDIO (Cardio Diagnostics), CELZ (Creative Medical Technology), HCWB (HCW Biologics), KPRX (Kiora Pharmaceuticals).
ALZN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACXP Acurx Pharmaceuticals | $1.03 | 3.00% | -74.25% | $6.24M |
| ADIL Adial Pharmaceuticals | $5.05 | 36.12% | -46.48% | $13.26M |
| APRE Aprea Therapeutics | $0.49 | 6.07% | -58.91% | $7.00M |
| BCDA BioCardia | $0.77 | 0.08% | -41.47% | $11.70M |
| CDIO Cardio Diagnostics | $1.65 | -2.37% | -35.55% | $4.88M |
| CELZ Creative Medical Technology | $0.44 | -5.64% | -84.88% | $3.34M |
| HCWB HCW Biologics | $0.74 | -3.77% | -93.87% | $2.31M |
| KPRX Kiora Pharmaceuticals | $0.82 | -0.46% | -57.24% | $3.63M |
| NRSN NeuroSense Therapeutics | $1.26 | -8.03% | -94.22% | $2.39M |
| PHIO Phio Pharmaceuticals | $0.71 | -0.74% | -42.80% | $8.55M |
| ALZN Alzamend Neuro | $1.02 | -1.92% | -55.84% | $4.92M |